ALB and non-small cell lung carcinoma: A novel immune–nutritional index, including five parameters (i.e., neutrophils, monocytes, platelets, lymphocytes, and albumin) in addition to other predictive biomarkers, may contribute to the prognostic value in NSCLC patients receiving treatment with ICIs.